Another investigation demonstrated the anticolitic effect of carvacol is associated with the protection of mucosal barrier through reducing translocation of NF-κB pathway and inhibiting TLR4 receptor activation pathway in DSS induced colitis model. The gene discussed is NFKB1; the disease is colitis.